In this 3-part series we’ve explored fundamental, detailed drivers and components for innovation in Latin America.

Local parameters shape the framework conditions for innovations in pharma in Latin America.

Intellectual Property (IP) protection is the lifeblood of the research-based pharmaceutical industry.

The United States promotes strong and effective IP protection around the world by means of the United States Patent and Trademark Office (USPTO) and its international intellectual property (IP) attaché program.

In an era with unprecedented longevity and declining birth rates, we are approaching a future defined by more people aged over 60 than under 15 for the first time in human history.